MRVI
Maravai Lifesciences Holdings Inc
NASDAQ: MRVI · HEALTHCARE · BIOTECHNOLOGY
$3.68
+5.75% today
Updated 2026-04-30
Market cap
$542.79M
P/E ratio
—
P/S ratio
2.92x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$2 – $4
Volume
1.8M
Maravai Lifesciences Holdings Inc (MRVI) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+9.6%
Last 4 quarters
Revenue YoY growth
-11.6%
Most recent quarter
EPS YoY growth
+33.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+7.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+14.1%
2026-02-25
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-0.04 | +43.0% | $3.12 | $3.56 | +14.1% |
| 2025-11-06 | $-0.08 | +0.0% | $2.87 | $2.87 | +0.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.07 | $-0.04 | +43.0% | $49.87M | -11.6% |
| 2025-09-30 | $-0.08 | $-0.08 | +0.0% | $41.63M | -36.2% |
| 2025-06-30 | $-0.07 | $-0.08 | -14.3% | $47.40M | -35.4% |
| 2025-03-31 | $-0.02 | $-0.02 | +0.0% | $46.85M | -27.0% |
| 2024-12-31 | $-0.04 | $-0.06 | -49.6% | $56.41M | -23.9% |
| 2024-09-30 | $-0.01 | $-0.02 | -100.0% | $65.20M | -2.5% |
| 2024-06-30 | $-0.00 | $-0.06 | -6875.0% | $73.40M | +6.5% |
| 2024-03-31 | $-0.03 | $-0.02 | +33.3% | $64.18M | -18.8% |
| 2023-12-31 | $-0.01 | $0.01 | +200.0% | $74.14M | — |
| 2023-09-30 | $0.01 | $-0.01 | -200.0% | $66.86M | — |
| 2023-06-30 | $0.01 | $-0.05 | -600.0% | $68.91M | — |
| 2023-03-31 | $0.04 | $0.03 | -25.0% | $79.03M | — |
Frequently asked questions
Has Maravai Lifesciences Holdings Inc beaten earnings estimates?
Maravai Lifesciences Holdings Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +9.6% over the last 3 quarters.
How does MRVI stock react to earnings?
MRVI stock has moved an average of +7.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Maravai Lifesciences Holdings Inc's revenue growth rate?
Maravai Lifesciences Holdings Inc reported year-over-year revenue growth of -11.6% in its most recent quarter, with EPS growing +33.3% year-over-year.